Innovative Financial And Technology Portfolio, Series 12
Ticker Symbol: FJXCZX
30 Holdings (As of Day of Deposit) |
Ticker |
Company Name |
Initial
Weight |
Price* |
Digital Payments |
ADYEY |
Adyen N.V. |
3.34% |
$15.99 |
AXP |
American Express Company |
3.36% |
212.49 |
SQ |
Block Inc. |
3.33% |
65.73 |
BR |
Broadridge Financial Solutions, Inc. |
3.34% |
195.16 |
FIS |
Fidelity National Information Services, Inc. |
3.32% |
62.96 |
FI |
Fiserv, Inc. |
3.31% |
147.93 |
FLT |
FLEETCOR Technologies, Inc. |
3.41% |
272.91 |
GPN |
Global Payments Inc. |
3.36% |
130.80 |
MA |
Mastercard Incorporated |
3.27% |
451.75 |
V |
Visa Inc. |
3.26% |
275.15 |
WEX |
WEX Inc. |
3.34% |
220.40 |
Financial Management Software |
ACN |
Accenture Plc |
3.34% |
362.95 |
INTU |
Intuit Inc. |
3.40% |
645.91 |
ORCL |
Oracle Corporation |
3.36% |
108.45 |
PCTY |
Paylocity Holding Corporation |
3.36% |
176.06 |
CRM |
Salesforce, Inc. |
3.39% |
286.39 |
SAP |
SAP SE |
3.37% |
176.60 |
NOW |
ServiceNow, Inc. |
3.47% |
752.84 |
VRSK |
Verisk Analytics, Inc. |
3.27% |
248.51 |
WDAY |
Workday, Inc. |
3.38% |
301.98 |
Fintech |
AX |
Axos Financial, Inc. |
3.32% |
53.13 |
BLK |
BlackRock, Inc. |
3.15% |
798.11 |
COF |
Capital One Financial Corporation |
3.35% |
137.39 |
CBOE |
Cboe Global Markets Inc. |
3.28% |
191.72 |
FICO |
Fair Isaac Corporation |
3.32% |
1,259.20 |
GS |
The Goldman Sachs Group, Inc. |
3.29% |
384.52 |
IBKR |
Interactive Brokers Group, Inc. |
3.33% |
103.34 |
JPM |
JPMorgan Chase & Co. |
3.31% |
179.73 |
MS |
Morgan Stanley |
3.31% |
85.35 |
SPGI |
S&P Global Inc. |
3.36% |
426.01 |
* As of the close of business on 2/20/24.
Market values are for reference only and are not indicative of your individual
cost basis.
Not FDIC Insured Not Bank Guaranteed May Lose Value |
Portfolio Summary |
Initial Date of Deposit |
2/21/2024 |
Initial Public Offering Price |
$10.00 per Unit |
Portfolio Ending Date |
2/20/2026 |
Cash CUSIP |
30334V220 |
Reinvestment CUSIP |
30334V238 |
Fee Accounts Cash CUSIP |
30334V246 |
Fee Accounts Reinvestment CUSIP |
30334V253 |
Sales Charges (based on a $10 public offering
price) |
Standard Accounts |
Transactional Sales Charges |
Initial: |
0.00% |
|
Deferred: |
2.25% |
Creation & Development Fee (C&D Fee) |
|
0.50% |
Maximum Sales Charge |
|
2.75% |
Fee/Wrap Accounts |
Maximum Sales Charge |
|
0.50% |
The deferred sales charge will be deducted in three monthly installments commencing 6/20/24. When the
public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price
exceeds $10.00 per unit, you will pay an initial sales charge. The maximum sales charge for investors in fee
accounts consists of the C&D fee. Investors in fee accounts are not assessed any transactional sales charges.
Standard accounts sales charges apply to units purchased as an ineligible asset. The C&D fee is a charge of
$0.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10.00 per
unit, the C&D fee will be less than 0.50%; if the price you pay is less than $10.00 per unit, the C&D fee will
exceed 0.50%. In addition to the sales charges listed, UITs are subject to annual operating expenses and
organization costs.
You should consider the portfolio's investment objectives, risks, and
charges and expenses carefully before investing. Contact your financial professional
or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Risk Considerations
An investment in this unmanaged unit investment trust should be made
with an understanding of the risks involved with owning common stocks, such as an economic recession and
the possible deterioration of either the financial condition of the issuers of the equity securities or the general
condition of the stock market.
You should be aware that the portfolio is concentrated in stocks in both the financials and information
technology sectors which involves additional risks, including limited diversification. The companies engaged
in the financials sector are subject to the adverse effects of volatile interest rates, economic recession,
decreases in the availability of capital, increased competition from new entrants in the field, and potential increased regulation. The companies engaged in the information technology sector are subject to fierce competition,
high research and development costs, and their products and services may be subject to rapid obsolescence. Technology company stocks, especially those which are Internet-related, may experience extreme price and volume
fluctuations that are often unrelated to their operating performance.
Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers.
An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger
companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.
Large capitalization companies may grow at a slower rate than the overall market.
As the use of Internet technology has become more prevalent in the course of business, the trust
has become more susceptible to potential operational risks through breaches in cybersecurity.
Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East have caused and could continue to cause significant market disruptions and volatility
within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.
The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease.
The value of the securities held by the trust may be subject to steep declines or increased
volatility due to changes in performance or perception of the issuers.
This UIT is a buy and hold strategy and investors should consider their ability to hold the trust
until maturity. There may be tax consequences unless units are purchased in an IRA or other
qualified plan.